On April 19, 2022, Fisher & Paykel Healthcare announced the U.S. launch of F&P Evora Full, a compact full-face mask for obstructive sleep apnea (OSA) treatment. The mask received FDA 510(k) clearance.
About F&P Evora Full
According to the company’s press release, the F&P Evora Full face mask features a compact seal that floats under the nose and stability wings to keep the seal stable. The minimal design provides patients with a clear line of sight and freedom of movement.
The mask connects to a single breathing tube to receive pressurized air from a PAP device. The cushion is available in three sizes, including extra small, small to medium and large, and the headgear is available in two sizes: standard and extra-large.
The Evora Full mask is available by prescription only.
About obstructive sleep apnea
OSA is a serious sleep disorder where the airway becomes repeatedly blocked during sleep, causing pauses in breathing. This condition, often marked by loud snoring and choking noises, can lead to oxygen deprivation, disrupting sleep and contributing to various health issues such as high blood pressure, heart disease, stroke and diabetes.
Read more industry news from the AASM.
